Viibryd and Hetlioz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Viibryd (vilazodone hydrochloride) and Hetlioz (tasimelteon). Common drug interactions include initial insomnia among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Viibryd and Hetlioz. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Viibryd?

Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. eHealthMe is studying from 11,106 Viibryd users. Check the latest studies of Viibryd.

What is Hetlioz?

Hetlioz has active ingredients of tasimelteon. eHealthMe is studying from 7,418 Hetlioz users. Check the latest studies of Hetlioz.



On Jul, 18, 2026

30 people who take Viibryd and Hetlioz together, and have interactions are studied.

Viibryd and Hetlioz drug interactions.

What are the common drug interactions of Viibryd and Hetlioz, by gender? *:

female:

  1. Initial insomnia (feeling of inadequate or poor-quality sleep)
  2. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  3. Drug ineffective
  4. Insomnia (sleeplessness)
  5. Sleep disorder
  6. Coma (state of unconsciousness lasting more than six hours)
  7. Asthenia (weakness)
  8. Depressed mood
  9. Fatigue (feeling of tiredness)
  10. Drug hypersensitivity

male:

  1. Drug ineffective
  2. Sinus disorder (disease of sinus)
  3. Insomnia (sleeplessness)
  4. Paranasal sinus discomfort
  5. Paranasal sinus hypersecretion
  6. Sinus pain
  7. Abdominal pain upper
  8. Death
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)

What are the common drug interactions of Viibryd and Hetlioz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug ineffective

30-39:

  1. Sinus disorder (disease of sinus)
  2. Coma (state of unconsciousness lasting more than six hours)

40-49:

  1. Initial insomnia (feeling of inadequate or poor-quality sleep)
  2. Insomnia (sleeplessness)
  3. Sleep disorder
  4. Abdominal pain upper
  5. Drug ineffective
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Nausea (feeling of having an urge to vomit)

50-59:

  1. Tension headache
  2. Drug ineffective
  3. Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
  4. Weight decreased
  5. Diarrhoea
  6. Impaired gastric emptying
  7. Nausea (feeling of having an urge to vomit)

60+:

  1. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  2. Asthenia (weakness)
  3. Depressed mood
  4. Fatigue (feeling of tiredness)
  5. Initial insomnia (feeling of inadequate or poor-quality sleep)
  6. Insomnia (sleeplessness)
  7. Drug ineffective

What are the existing conditions these people have? *

  1. Circadian Rhythm Sleep Disorder (family of sleep disorders affecting, among other things, the timing of sleep): 8 people, 26.67%
  2. Stress And Anxiety: 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Viibryd and Hetlioz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Viibryd and Hetlioz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Viibryd:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hetlioz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Viibryd and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hetlioz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on vilazodone hydrochloride and tasimelteon (the active ingredients of Viibryd and Hetlioz, respectively), and Viibryd and Hetlioz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: